The Branding Process: Part 1

In the process of (finally) presenting all of my work from the past semester, here is the first part of my branding assignments from my Advanced Graphic Design class with Donna Hughes. The first part of the branding process was logo development. A logo should embody an organization or product, therefore a designer should dedicate an ample amount of time in research. Donna taught us this by requiring us to complete a few forms, which included a product identity, as well as filling out a concepting matrix, which included word, image, and color association list. I decided to create a logo for an imaginary pharmaceutical drug, Promeaga. Why? I didn't want to mimic anything on the market, recreate present branding, and most importantly, I wanted to put myself in a real-life situation with creating a new logo. Let's take a look at the process with the Promeaga logo.

Product Identity
Name of product: Promeaga (Echinomycin doxorubictin)

What exactly does the product do?
Promeaga is a cancer suppressant pharmaceutical that successfully repairs the human p53 gene, the transcription factor that prevent genome mutation by initiating apoptosis (premeditated cell death). In most cancers this transcription factor is mutated, therefore Promeaga would be able to restore the function of apoptosis in cancer patients, providing a better chance of restoring normal function in cancer patients.

Describe the industry of which the product is a part.
Promeaga is part of the new findings and experimentation of Merck & Co. Merck & Co is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive e fforts to increase access to medicines through far-reaching programs that not only donate Merck medicines, but help deliver them to the people who need them.

How does the product fit in this industry? What is unique about it that sets it apart from others in the market? What is similar that keeps it competitive within the market?)
Promeaga is the first product to benefit cancer patients of all kinds without the negative e ffects of chemotherapy. This drug provides a step ahead towards the actual cure for cancer. Though this drug is not the cure-all, Promeaga targets the transcription factor that initiates apoptosis, which stops the mutated cells from multiplying and make the cancer deadly. With the death of cancer-causing cells, there is a better chance of survival normal functioning cells and the patient. This drug, as beneficial as it is, is one step closer to the cure for cancer, though it does not fully provide society with the cure for cancer. Therefore, there is a sufficient amount of research yet to be done by pharmaceutical companies to find the cure.

Audience Profile Who is the audience (end user) for the product? Describe their personality as a group.
The audience in for patients with all types of cancer that would like to see an alternative to treatment other than chemotherapy. They are likely very sick and exhausted from dealing with their cancer. The patients will most likely be happy to know that there is a better treatment option than chemotherapy, and one that could potentially cure many of numerous types of cancers. Cancer patients tend to be hopeful through their treatment and are more willing to try new procedures. They want to rid themselves of the cancer with as little pain and su ffering as possible.

What is the accepted/preferred visual language of the audience? Research example of what they are used to seeing and what is successful in communicating with them.
The visual language for cancer patients follows a positive outlook for curing cancer. Though the drugs and therapies are not highly advertised, organizations for all types of cancer show images of hope, love, family, strength, life. All imagery is active and positive. Though the audience is faced with the possibility of a shortened life, the advertising takes them away from this to keep them positive during their treatment and not willing to give up on their battle.

What is the primary message you want the audience to receive about the product? (This should be a simple, clear answer—one concise sentence.)
Promeaga provides cancer patients with more hope and promise than any other cancer treatment.

What is the secondary message you want the audience to receive about the product?
Promeaga gives cancer patients their lives back by providing a more comfortable treatment.



After product identity was in place, I was able to go to the concepting matrix. Though this matrix did not have to be followed, it is a fantastic tool for experimentation and spurring thought and creativity. Afterwards, I worked on thumbnails of possible logo ideas in black and white. Below are images of these worksheets as well as a my top choices for the final logo. Which one do you think I chose to finish?